| 101 |
Design, synthesis, and biological evaluation of new pyrimidine-5-carbonitrile derivatives bearing 1,3-thiazole moiety as novel anti-inflammatory EGFR inhibitors with cardiac safety profile |
2021 |
| 102 |
Design, synthesis, and biological evaluation of novel EGFR inhibitors containing 5-chloro-3-hydroxymethyl-indole-2-carboxamide scaffold with apoptotic antiproliferative activity |
2021 |
| 103 |
Design, Synthesis, Biological Evaluation, and Computational Studies of Novel Tri-Aryl Imidazole-Benzene Sulfonamide Hybrids as Promising Selective Carbonic Anhydrase IX and XII Inhibitors |
2021 |
| 104 |
Development of new hetero‑steroid hybrids with antiproliferative activity against MCF‑7 breast cancer cells |
2021 |
| 105 |
Enhanced molecular imprinted electrochemical sensing of histamine based on signal reporting nanohybrid |
2021 |
| 106 |
FAK inhibitors as promising anticancer target: Present and future directions |
2021 |
| 107 |
Globally approved EGFR inhibitors: insights into their syntheses, targeted kinases, biological activity, receptor interactions and metabolism |
2021 |
| 108 |
New quinoline/1,2,4-triazole hybrids as dual inhibitors of COX-2/5-LOX and inflammatory cytokines: Design, synthesis, and docking study |
2021 |
| 109 |
Novel 1,2,4-oxadiazole/pyrrolidine hybrids as DNA gyrase and Topoisomerase IV inhibitors with potential antibacterial activity |
2021 |
| 110 |
Novel Urea Linked Ciprofloxacin-Chalcone Hybrids having Antiproliferative Topoisomerases I/II Inhibitory Activities and Caspases-Mediated Apoptosis |
2021 |
